MarketCap
Repligen Corporation RGEN
$ 174.73
4.01%
Facebook
X
Telegram
Repligen Corporation Interest Expense | RGEN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Repligen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.82 M | -5.17 M | 1.95 M | 1.16 M | -1.17 M | 10.8 M | 9.29 M | 6.71 M | 6.44 M | 3.77 M | 32 K | 50 K | 50 K | 56.7 K | 26.2 K | 12.7 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 M | -5.17 M | 2.3 M |
Quarterly Interest Expense Repligen Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -273 K | -750 K | -804 K | 3.5 M | -286 K | - | 3.1 M | -215 K | -3.54 M | - | 895 K | 274 K | 270 K | - | 329 K | 271 K | 292 K | - | 2.86 M | 3.14 M | 2.75 M | - | 3.05 M | 3 M | 2.98 M | - | 2.86 M | 1.74 M | 1.73 M | - | 1.69 M | 1.67 M | 1.65 M | 1.64 M | 1.62 M | 1.6 M | 1.58 M | 1.57 M | 1.56 M | 638 K | 5 K | 8 K | 8 K | 8 K | 9 K | 12 K | 11 K | 13 K | 14 K | -54 K | 11.7 K | 12.4 K | 13.5 K | 14 K | -7 K | 27.4 K | 22.4 K | 28 K | 13.5 K | 13.5 K | 13 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.5 M | -3.54 M | 789 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M |  USA |
 |
Alcon
ALC
|
204 M | $ 67.76 | 0.03 % | $ 33.4 B |  Schweiz |
 |
AngioDynamics
ANGO
|
3.93 M | $ 15.68 | 1.1 % | $ 651 M | USA |
 |
AtriCure
ATRC
|
683 K | $ 56.22 | 0.77 % | $ 2.68 B | USA |
 |
Baxter International
BAX
|
290 M | $ 23.71 | 0.25 % | $ 12.2 B | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 185.92 | 1.65 % | $ 53.5 B | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 53.27 | 0.58 % | $ 10.6 B | USA |
 |
BioLife Solutions
BLFS
|
1.82 M | $ 36.39 | 2.71 % | $ 1.74 B | USA |
 |
electroCore
ECOR
|
14.9 K | $ 10.05 | 2.97 % | $ 85.3 K | USA |
 |
Glaukos Corporation
GKOS
|
479 K | $ 171.68 | 0.34 % | $ 9.82 B | USA |
 |
Haemonetics Corporation
HAE
|
-28.7 M | $ 106.2 | 0.03 % | $ 5.01 B | USA |
 |
Harvard Bioscience
HBIO
|
-2.66 M | $ 7.98 | 0.75 % | $ 354 M | USA |
 |
ICU Medical
ICUI
|
93.3 M | $ 155.88 | 0.72 % | $ 3.84 B | USA |
 |
InfuSystem Holdings
INFU
|
2 K | $ 12.26 | 0.08 % | $ 253 M | USA |
 |
iRhythm Technologies
IRTC
|
5.44 M | $ 111.88 | 2.95 % | $ 3.58 B | USA |
 |
Repro Med Systems
KRMD
|
9.91 K | $ 3.16 | 0.64 % | $ 146 M | USA |
 |
LeMaitre Vascular
LMAT
|
5.18 M | $ 80.24 | 0.22 % | $ 1.82 B | USA |
 |
Microbot Medical
MBOT
|
-5 K | $ 1.44 | 0.34 % | $ 65.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.4 | 1.42 % | $ 32.8 M | USA |
 |
Merit Medical Systems
MMSI
|
-2.39 M | $ 86.18 | 0.76 % | $ 5.1 B | USA |
 |
Nephros
NEPH
|
-78 K | $ 4.29 | 0.45 % | $ 45.5 M | USA |
 |
Envista Holdings Corporation
NVST
|
-2.3 M | $ 24.73 | 0.94 % | $ 4.15 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 66.91 | 0.53 % | $ 216 B | USA |
 |
Pulse Biosciences
PLSE
|
-52 K | $ 55.2 | 1.83 % | $ 3.72 B | USA |
 |
ResMed
RMD
|
-9.15 M | $ 229.44 | 2.92 % | $ 33.4 B | USA |
 |
Retractable Technologies
RVP
|
152 K | $ 0.68 | 0.03 % | $ 20.4 M | USA |
 |
STAAR Surgical Company
STAA
|
2.25 M | $ 22.45 | 1.81 % | $ 1.11 B | USA |
 |
STERIS plc
STE
|
9.8 M | $ 210.28 | 1.36 % | $ 20.6 B | USA |
 |
Teleflex Incorporated
TFX
|
85.1 M | $ 129.02 | 0.19 % | $ 5.76 B | USA |
 |
OraSure Technologies
OSUR
|
229 K | $ 3.46 | 2.67 % | $ 254 M | USA |
 |
Utah Medical Products
UTMD
|
-120 K | $ 74.63 | 5.6 % | $ 242 M | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 365.0 | 2.76 % | $ 26.4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
24 M | $ 9.83 | 0.62 % | $ 1.96 B | USA |
 |
Stereotaxis
STXS
|
2 K | $ 1.32 | 3.1 % | $ 120 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-8 K | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
84 K | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
300 K | - | - | $ 9.59 B | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |